Heartland Advisors Inc. raised its stake in shares of Aspen Aerogels Inc. (NYSE:ASPN) by 630.0% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 730,000 shares of the company’s stock after buying an additional 630,000 shares during the period. Heartland Advisors Inc. owned approximately 3.55% of Aspen Aerogels worth $4,351,000 as of its most recent SEC filing.

A number of other hedge funds have also added to or reduced their stakes in the stock. Jacobs Levy Equity Management Inc. acquired a new stake in Aspen Aerogels during the first quarter valued at about $371,000. Balter Liquid Alternatives LLC increased its position in Aspen Aerogels by 162.8% in the first quarter. Balter Liquid Alternatives LLC now owns 33,236 shares of the company’s stock valued at $150,000 after buying an additional 20,590 shares during the last quarter. Tocqueville Asset Management L.P. increased its position in Aspen Aerogels by 35.1% in the second quarter. Tocqueville Asset Management L.P. now owns 657,080 shares of the company’s stock valued at $3,266,000 after buying an additional 170,650 shares during the last quarter. GSA Capital Partners LLP increased its position in Aspen Aerogels by 71.6% in the second quarter. GSA Capital Partners LLP now owns 44,129 shares of the company’s stock valued at $219,000 after buying an additional 18,419 shares during the last quarter. Finally, Royce & Associates LP increased its position in Aspen Aerogels by 16.1% in the second quarter. Royce & Associates LP now owns 113,752 shares of the company’s stock valued at $565,000 after buying an additional 15,756 shares during the last quarter. Hedge funds and other institutional investors own 75.16% of the company’s stock.

Institutional Ownership by Quarter for Aspen Aerogels (NYSE:ASPN)

Shares of Aspen Aerogels Inc. (NYSE:ASPN) traded down 2.00% during midday trading on Monday, reaching $3.92. The company had a trading volume of 10,525 shares. The company has a 50 day moving average price of $5.26 and a 200-day moving average price of $4.94. The firm’s market capitalization is $80.68 million. Aspen Aerogels Inc. has a one year low of $3.38 and a one year high of $6.85.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings results on Thursday, November 3rd. The company reported ($0.13) EPS for the quarter, missing analysts’ consensus estimates of ($0.09) by $0.04. The company earned $29.60 million during the quarter, compared to the consensus estimate of $29.05 million. Aspen Aerogels had a negative return on equity of 3.82% and a negative net margin of 3.64%. The company’s revenue for the quarter was down 6.0% compared to the same quarter last year. During the same period last year, the firm posted ($0.11) EPS. On average, analysts anticipate that Aspen Aerogels Inc. will post ($0.44) EPS for the current fiscal year.

TRADEMARK VIOLATION WARNING: This article was first published by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are reading this article on another website, it was stolen and republished in violation of United States & international copyright laws. The correct version of this article can be viewed at https://www.thecerbatgem.com/2016/11/28/aspen-aerogels-inc-aspn-shares-bought-by-heartland-advisors-inc.html.

Several equities analysts have recently commented on ASPN shares. Canaccord Genuity reaffirmed a “buy” rating and issued a $8.50 target price on shares of Aspen Aerogels in a research report on Thursday, August 4th. Zacks Investment Research raised Aspen Aerogels from a “sell” rating to a “hold” rating in a research report on Wednesday, October 5th. Seaport Global Securities downgraded Aspen Aerogels from a “buy” rating to a “neutral” rating in a research report on Friday, November 4th. JPMorgan Chase & Co. decreased their target price on Aspen Aerogels from $8.00 to $7.00 and set an “overweight” rating on the stock in a research report on Friday, August 5th. Finally, Craig Hallum started coverage on Aspen Aerogels in a research report on Tuesday, September 20th. They issued a “buy” rating and a $10.00 target price on the stock. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and four have issued a buy rating to the company’s stock. The company has an average rating of “Hold” and an average target price of $7.50.

About Aspen Aerogels

Aspen Aerogels, Inc is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in energy infrastructure facilities. The Company also performs contract research services for various federal and non-federal government agencies, including the Department of Defense, the Department of Energy and other institutions.

5 Day Chart for NYSE:ASPN

Receive News & Stock Ratings for Aspen Aerogels Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aspen Aerogels Inc. and related stocks with our FREE daily email newsletter.